Document:

Form of Restricted Stock Unit Agreement

 Exhibit 10.4 
 CONSTANT CONTACT, INC. 
 Restricted Stock Unit Agreement 

Under 2012 Inducement Award Plan 
 (Time-Based Vesting) 
 AGREEMENT made between Constant Contact, Inc., a
Delaware corporation (the “Company”), and                  (“you”) as of this
             day of June, 2012 (the “Effective Date”), immediately after the closing of the transactions contemplated by that certain Agreement and Plan of
Merger by and among the Company, Match Acquisition Corporation, SinglePlatform, Corp. and the Stockholder Representative (as defined therein), dated as of June 12, 2012. 
 For valuable consideration, receipt of which is acknowledged, the Company and you agree as follows: 
  

	1.	Grant of RSUs. 

Effective as of the Effective Date, and subject to the terms and conditions set forth in this Agreement and in the Constant Contact, Inc.
2012 Inducement Award Plan (the “Plan”), the Company has granted you Restricted Stock Units (“RSUs”) providing you with the right to receive
                 shares of common stock (“Common Stock”), $0.01 par value per share, of the Company (the
“Shares”). 
  

	2.	Vesting and Forfeiture. 

 (a)        While you remain employed by, or engaged to provide services on an individual basis to, the Company, 30% of the RSUs will vest on the first anniversary
of the Effective Date, 35% of the RSUs will vest on each of the second and third anniversaries of the Effective Date, such that 100% of the RSUs will be fully vested on the third anniversary of the Effective Date. The date upon which any of the RSUs
vest will be considered a “Vesting Date” for the RSUs that vest on that date. Any fractional Shares that would otherwise vest as of a particular date will be rounded down and carried forward to the next Vesting Date until a
whole Share can be issued. 
 (b)        Absent any contrary provision in the Plan or
any other applicable plan or agreement, if you cease to be employed by, or engaged to provide services on an individual basis to, the Company for any reason or no reason, you will immediately and automatically forfeit all rights to any of your RSUs
that have Vesting Dates after the date your employment or engagement with the Company ends. 
  

	3.	Issuance of Shares. 

 Subject to the terms and conditions of this Agreement (including any Withholding Tax obligations), after each Vesting Date, the Company will issue to you (or your estate, or an account at a brokerage firm
designated by the Company), within three (3) business days following such Vesting Date, one Share for each RSU that vested on such Vesting Date. Until each applicable Vesting Date, you will have no rights to any Shares, and until the Company
delivers the Shares to you, you will not have any rights associated with such Shares, including without limitation voting rights, dividends or dividend equivalents. 

	4.	Transferability. 

The RSUs and Shares they represent may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of (whether by
operation of law or otherwise) (collectively, a “transfer”), except that this Agreement may be transferred by the laws of descent and distribution or as otherwise permitted under the Plan. You may only transfer the Shares
that may be issued pursuant to this Agreement following a Vesting Date that covers them. 
  

	5.	Withholding Taxes. 

(a)        You acknowledge that you have reviewed with your own tax advisors the federal, state,
local and foreign tax consequences of this investment and the actions contemplated by this Agreement. You affirm that you are relying solely on such advisors and not on any statements or representations of the Company or any of its agents.

 (b)        The Company’s obligation to deliver Shares to you upon or after the
vesting of the RSUs shall be subject to your satisfaction of all income tax (including federal, state and local taxes), social insurance, payroll tax, payment on account or other tax related withholding requirements, as determined by the Company
(“Withholding Taxes”). 
 (c)        You acknowledge and agree
that the Company has the right to deduct from payments of any kind otherwise due to you any Withholding Taxes to be withheld with respect to the actions contemplated by this Agreement. 

(d)        Without limiting the generality of the foregoing Section 5(c), except as provided
in the next sentence, the Company shall withhold a number of Shares issuable in payment of any vested RSUs having a Fair Market Value, as of the Vesting Date of such RSUs, equal to the Withholding Taxes with respect to such RSUs. If the Company
cannot (under applicable legal, regulatory, listing or other requirements, or otherwise) satisfy such Withholding Taxes in such method, the Company may satisfy such Withholding Taxes by any one or combination of the following methods: (i) by
requiring you to pay such Withholding Taxes in cash or by check; (ii) by deducting such Withholding Taxes out of any other compensation otherwise payable to you by the Company; and/or (iii) by allowing you to surrender shares of Common
Stock which (x) in the case of shares initially acquired from the Company (upon exercise of a stock option or otherwise), have been owned by you for such period (if any) as may be required to avoid a charge to the Company’s earnings, and
(y) have a Fair Market Value on the date of surrender equal to such Withholding Taxes. The Company is hereby authorized to take such actions as are necessary to effect the withholding of any and all such Withholding Taxes in accordance with
this Section 5(d). For purposes of this Section 5(d), the “Fair Market Value” of a Share as of any date shall be equal to the last reported sale price of the Common Stock on the NASDAQ Stock Market (or any other
stock exchange or over-the-counter market on which the Company’s Common Stock is then traded) on such date. 
  

	6.	Securities Laws. 

Notwithstanding any other provision of the Plan or this Agreement, the Company will not be required to issue, and you may not sell,
assign, transfer or otherwise dispose of, any shares of Common Stock received as payment of the RSUs, unless (a) there is in effect with respect to the 

 
shares of Common Stock received as payment of the RSUs a registration statement under the Securities Act of 1933, as amended, and any applicable state or foreign securities laws or an exemption
from such registration, and (b) there has been obtained any other consent, approval or permit from any other regulatory body that the Compensation Committee (the “Committee”) of the Company’s Board of Directors, in
its sole discretion, deems necessary or advisable. The Company may condition such issuance, sale or transfer upon the receipt of any representations or agreements from the parties involved, and the placement of any legends on certificates
representing Common Stock received as payment of the RSUs, as may be deemed necessary or advisable by the Company to comply with such securities law or other restrictions. 

 

	7.	Provisions of the Plan. 

 This Agreement is subject to the provisions of the Plan, a copy of which is furnished to you with this Agreement. Any capitalized terms used in this Agreement but not otherwise defined in the Agreement
shall have the same meaning as in the Plan. 
  

	8.	Miscellaneous. 

(a)        Section 409A. This Agreement is intended to comply with the requirements
of Section 409A and shall be construed consistently therewith. In any event, the Company makes no representation or warranty and will have no liability to you or any other person, other than with respect to payments made by the Company in
violation of the provisions of this Agreement, if any provisions of or payments under this Agreement are determined to constitute deferred compensation subject to Section 409A but not to satisfy the conditions of that section. 

(b)        Unsecured Creditor. This Agreement shall create a contractual obligation on the
part of Company to make payment of the RSUs credited to your account at the time provided for in this Agreement. Neither you nor any other party claiming an interest in the RSUs or related stock hereunder shall have any interest whatsoever in any
specific assets of the Company. Your right to receive payments hereunder shall be that of an unsecured general creditor of Company. 
 (c)        Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law. 
 (d)        Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by
the Board of Directors of the Company or the Committee. 
 (e)        Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the Company and you and its and your respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set
forth in Section 4 of this Agreement. 
 (f)        Notice. Except as
provided in Section 8(i), all notices required or permitted hereunder shall be in writing or provided and deemed effectively given upon personal delivery or five calendar days after deposit in the United States Post Office, by registered or
certified mail, 

 
postage prepaid, addressed to the other party hereto at, for the Company, its primary business address (attention: Chief Human Resources Officer / General Counsel) and, for you, at your home
address as reflected in the records of the Company, or at such other address or addresses as either party shall designate to the other in accordance with this Section 8(f). 

(g)        Entire Agreement. This Agreement and the Plan constitute the entire agreement
between the parties, and supersede all prior agreements and understandings, relating to the subject matter of this Agreement. 

(h)        Governing Law. This Agreement shall be construed, interpreted and enforced in
accordance with the internal laws of the State of Delaware without regard to any applicable conflicts of laws. 

(i)        Electronic Delivery. The Company may, in its sole discretion, decide to deliver
any documents related to participation in the Plan or awards granted under the Plan by electronic means or to request your consent to participate in the Plan by electronic means or allow you to provide notices by electronic means. You hereby consent
to receive such documents by electronic delivery and, if requested, you agree to participate in the Plan through anon-line or electronic system established and maintained by the Company or another third party designated by the Company. 

(j)        Your Acknowledgments. You acknowledge that you: (i) have read this
Agreement; (ii) have been represented in the preparation, negotiation and execution of this Agreement by legal counsel of your own choice or have voluntarily declined to seek such counsel; (iii) understand the terms and consequences of
this Agreement; and (iv) are fully aware of the legal and binding effect of this Agreement. 
 [Signatures on Pages
Following] 

 IN WITNESS WHEREOF, the Company has caused this grant to be executed under its corporate
seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

	
	CONSTANT CONTACT, INC.
	
	
By:                       
                                         
                

	
	 Name:
                                         
                                

	
	 Title:  
                                         
                                

 Dated:
                             

 PARTICIPANT’S ACCEPTANCE 

By signing below (or by accepting the foregoing grant through such other means as may be established by the Company or its third-party
administrator from time to time), I hereby accept the foregoing grant and agree to the terms and conditions thereof and acknowledge receipt of a copy of the Plan. 

 

			
	PARTICIPANT:
	
	 
		
	 Address:  
	 	 
	
	 

 Dated:EX-10.7

 Exhibit 10.7 
 PROMISSORY NOTE 
 June 7, 2012 

$135,000 
 Hopkinton, Massachusetts

 FOR VALUE RECEIVED, Alseres Pharmaceuticals, Inc. (the “Maker”), promises to pay to Robert L Gipson, or order, at
the offices of Robert L. Gipson, c/o Ingalls & Snyder LLC, 61 Broadway, New York, New York 10006 or at such other place as the holder of this Note may designate, the principal sum of $135,000, together with interest on the unpaid principal
balance of this Note from time to time outstanding at the rate of 7% per year until paid in full. All principal and accrued interest shall be due and payable on demand of the Holder. 
 Interest on this Note shall be computed on the basis of a year of 365 days for the actual number of days elapsed. All payments by the Maker under this Note shall be in immediately available funds.

 Every amount overdue under this Note shall bear interest from and after the date on which such amount first became overdue at an annual rate
which is two (2) percentage points above the rate per year specified in the first paragraph of this Note. Such interest on overdue amounts under this Note shall be payable on demand and shall accrue and be compounded monthly until the
obligation of the Maker with respect to the payment of such interest has been discharged (whether before or after judgment). 
 In no event
shall any interest charged, collected or reserved under this Note exceed the maximum rate then permitted by applicable law and if any such payment is paid by the Maker, then such excess sum shall be credited by the holder as a payment of principal.

 All payments by the Maker under this Note shall be made without set-off or counterclaim and be free and clear and without any deduction or
withholding for any taxes or fees of any nature whatever, unless the obligation to make such deduction or withholding is imposed by law. The Maker shall pay and save the holder harmless from all liabilities with respect to or resulting from any
delay or omission to make any such deduction or withholding required by law. 
 Whenever any amount is paid under this Note, all or part of the
amount paid may be applied to principal, premium or interest in such order and manner as shall be determined by the holder in its discretion. 

No reference in this Note to any guaranty or other document shall impair the obligation of the Maker, which is absolute and unconditional, to pay all
amounts under this Note strictly in accordance with the terms of this Note. 
 The Maker agrees to pay on demand all costs of collection,
including reasonable attorneys’ fees, incurred by the holder in enforcing the obligations of the Maker under this Note. 

 No delay or omission on the part of the holder in exercising any right under this Note shall operate as a
waiver of such right or of any other right of such holder, nor shall any delay, omission or waiver on any one occasion be deemed a bar to or waiver of the same or any other right on any future occasion. The Maker and every endorser or guarantor of
this Note regardless of the time, order or place of signing waives presentment, demand, protest and notices of every kind and assents to any extension or postponement of the time of payment or any other indulgence, to any substitution, exchange or
release of collateral, and to the addition or release of any other party or person primarily or secondarily liable. 
 This Note may be prepaid
in whole or in part at any time or from time to time upon five days’ prior written notice with the consent of the holder, with the giving of such consent to be in the sole discretion of the holder. Any such prepayment shall be without penalty
or premium. 
 None of the terms or provisions of this Note may be excluded, modified or amended except by a written instrument duly executed on
behalf of the holder expressly referring to this Note and setting forth the provision so excluded, modified or amended. 
 All rights and
obligations hereunder shall be governed by the laws of the Commonwealth of Massachusetts and this Note is executed as an instrument under seal. 
 Alseres Pharmaceuticals, Inc. 
 By: /s/ Kenneth L. Rice Jr

 Title: EVP & CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]